Literature DB >> 11236627

[Partial nucleotide sequences of hepatitis E viruses isolated from patients in 14 cities of China].

H Zhuang1, K Li, W Zhu.   

Abstract

OBJECTIVE: To investigate the genotypes of hepatitis E viruses isolated in China.
METHODS: The partial genome of open reading frame 2 (nt6461-6860, nt5994-6294) of 45 HEV isolated from patients in 14 cities of China was amplified and sequenced using polymerase chain reaction and direct sequencing.
RESULTS: 41 of 45 isolates (91%) shared the same genotype with HEV Burma strain (B), with nucleotide identities higher than 98% with the representative HEV Chinese strain. Only 4 HEV isolates were significantly divergent from the 3 prototype strains of HEV, with nucleotide identities of 77%-80% with HEV Burmese/Chinese strain, 74%-76% with Mexico strain and 74%-77% with the newly discovered HEV US/Swine strain, respectively. Phylogenetic analysis suggested that these 4 isolates represented 2 different subtypes belonging to a novel genotype of HEV, which was significantly divergent from the prototype Mexican, Burmese and US/Swine isolates.
CONCLUSION: Among patients with hepatitis E in China, most are infected with the Chinese prototype HEV, and only a small part with the new genotype HEV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11236627

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Hepatitis E virus infection among animals and humans in Xinjiang, China: possibility of swine to human transmission of sporadic hepatitis E in an endemic area.

Authors:  Hongwei Fu; Lingjun Li; Yonghong Zhu; Ling Wang; Jiabao Geng; Yibin Chang; Cheng Xue; Gang Du; Yaning Li; Hui Zhuang
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China.

Authors:  Rong-Cheng Li; Sheng-Xiang Ge; Yan-Ping Li; Ying-Jie Zheng; Yi Nong; Qing-Shun Guo; Jun Zhang; Mun-Hon Ng; Ning-Shao Xia
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.